AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Imunon, Inc. Director's Dealing 2023

Dec 11, 2023

35124_dirs_2023-12-11_f103924d-8e6e-4d9d-ab7d-685f05973175.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2023-12-07

Reporting Person: Hazard Sebastien (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct